Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany

Published: 1/12/2016
Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany
Source: WWW.PHARMACEUTICAL-TECHNOLOGY.COM

Takeda Pharmaceuticals has announced plans to invest more than €100m to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.

Read more
Related news
Comment
FACEBOOK